Satoru Oi - Concepedia

Author

Satoru Oi

Takeda (Japan)

Also Known As

S. OI, Satoru OI, Satoru Oi

Publications

535

Citations

H-Index

Concepts

All Affiliations

Takeda (Japan)Takeda (United States)

About

Satoru Oi is an author at Takeda (Japan) specializing in natural sciences, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	528
2	Natural Sciences	7	7	528
3	Biochemistry	7	7	528
4	Pharmacology	7	7	528
5	Chemical Biology	4	4	177

Satoru Oi

Publications

528

Citations

H-Index

Page 1

	Year	Citations
Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds. Yū Momose, Kanji Meguro, Hitoshi Ikeda, Chemical and Pharmaceutical Bulletin Pharmaceutical ScienceBiological ActivitiesPharmacotherapyAntidiabetic AgentsHeterocycle Chemistry	1991	284
Synthesis of Peptide Aldehyde Derivatives as Selective Inhibitors of Human Cathepsin L and Their Inhibitory Effect on Bone Resorption Tsuneo Yasuma, Satoru Oi, Nobuo Choh, Journal of Medicinal Chemistry SclerostinBone ResorptionBone Collagen DegradationHuman Cathepsin LChemical Biology	1998	75
Discovery of a 3-Pyridylacetic Acid Derivative (TAK-100) as a Potent, Selective and Orally Active Dipeptidyl Peptidase IV (DPP-4) Inhibitor Yasufumi Miyamoto, Yoshihiro Banno, Tatsuhiko Fujimoto, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryPharmacotherapyChemical BiologyMedicinal Chemistry	2011	54
Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554 Yoshihiro Banno, Yasufumi Miyamoto, Mitsuru Sasaki, Bioorganic & Medicinal Chemistry Medicinal ChemistryUnique InteractionBioorganic ChemistryBiochemistryNatural Sciences	2011	42
Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554 Hironobu Maezaki, Yoshihiro Banno, Yasufumi Miyamoto, Bioorganic & Medicinal Chemistry Medicinal ChemistryDrug TargetBiochemistryMedicineNatural Sciences	2011	28
Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125 Yasufumi Miyamoto, Yoshihiro Banno, Tatsuhiko Fujimoto, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistry3-Pyridylacetamide DerivativesMedicineNatural Sciences	2010	25
Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554 Hironobu Maezaki, Michiko Tawada, Yoshihiro Banno, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBiochemistryNatural SciencesMedicine	2017	20

Page 1